Evidence map›Paper›PMID 36195688›Full record

ArticleNature medicine2022

Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.

Michela Garofalo, Giulia Romano, Gianpiero Di Leva, Gerard Nuovo, Young-Jun Jeon, Apollinaire Ngankeu, Jin Sun, Francesca Lovat, Hansjuerg Alder, Gerolama Condorelli and 7 more

RetractedOpen access · bronzeAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Michela GarofaloDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Giulia RomanoIstituto Di Ricovero e Cura a Carattere Scientifico Studio Diagnostica Nucleare (SDN), Naples, Italy.
Gianpiero Di LevaDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Gerard NuovoDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Young-Jun JeonDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Apollinaire NgankeuDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Jin SunDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Francesca LovatDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Hansjuerg AlderDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Gerolama CondorelliDepartment of Cellular and Molecular Biology and Pathology, Institute of Experimental Endocrinology and Oncology, Consiglio Nazionale delle Ricerche (IEOS-CNR), Faculty of Biotechnological Science, 'Federico II' University of Naples, Napoli, Italy.
Jeffrey A EngelmanMassachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Mayumi OnoDepartment of Pharmaceutical Oncology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Jin Kyung RhoDepartment of Pulmonary and Critical Care Medicine, University of Ulsan, Seoul, Korea.
Luciano CascioneDepartment of Clinical and Molecular Biomedicine, University of Catania, Catania, Italy.
Stefano VoliniaDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
Kenneth P NephewDepartment of Cellular and Integrated Physiology, Medical Sciences Program, Indiana University School of Medicine and the Indiana University Simon Cancer Center, Bloomington, Indiana, USA.
Carlo M CroceDepartment of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA. carlo.croce@osumc.edu.
The Ohio State University · USHarvard University · USIndiana University Bloomington · USInstitute for Experimental Endocrinology and Oncology · ITKyushu University · JPSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Catania · ITUniversity of Ulsan · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36195688
PMCPMC9675728
OpenAlexW4301394290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.